Zentalis Pharmaceuticals Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Zentalis Pharmaceuticals Inc had 31.93M in cash and cash equivalents.

Zentalis Pharmaceuticals Inc reported 72.76M in total liabilities as of the latest reported quarter, including 36.56M in current liabilities and 36.20M in non-current liabilities.

As of the latest reported quarter, Zentalis Pharmaceuticals Inc's total assets were 288.97M, consisting of 253.19M in current assets and 35.78M in non-current assets.

Zentalis Pharmaceuticals Inc reported 216.20M in total shareholders' equity as of the latest reported quarter.